Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer cell

Showing results (401-410 of 4,097) with videos related to

Pageof 410
Sort By:
Cancer Cell|March 12, 2015
Genomic analysis of smoothened inhibitor resistance in basal cell carcinomaHayley J Sharpe, Gregoire Pau, Gerrit J Dijkgraaf, et al.
Cancer Cell|March 12, 2015
Smoothened variants explain the majority of drug resistance in basal cell carcinomaScott X Atwood, Kavita Y Sarin, Ramon J Whitson, et al.
Cancer Cell|March 12, 2015
A cytoplasmic NF-κB interacting long noncoding RNA blocks IκB phosphorylation and suppresses breast cancer metastasisBodu Liu, Lijuan Sun, Qiang Liu, et al.
Cancer Cell|August 5, 2020
Clinical Challenges of Immune Checkpoint InhibitorsMaria de Miguel, Emiliano Calvo
Cancer Cell|May 12, 2023
Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in gliomaMohanraj Ramachandran, Alessandra Vaccaro, Tiarne van de Walle, et al.
Cancer Cell|April 28, 2023
Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancerMary Y Wu, Scott T C Shepherd, Annika Fendler, et al.
Cancer Cell|April 16, 2015
Releasing the brakes: targeting FcγRIIB on B cells to enhance antibody-dependent lymphoma immunotherapyMichaela Seeling, Falk Nimmerjahn
Cancer Cell|April 16, 2015
Antagonistic human FcγRIIB (CD32B) antibodies have anti-tumor activity and overcome resistance to antibody therapy in vivoAli Roghanian, Ingrid Teige, Linda Mårtensson, et al.
Cancer Cell|April 16, 2015
Synergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2Eric F Zhu, Shuning A Gai, Cary F Opel, et al.
Cancer Cell|April 16, 2015
TGIF governs a feed-forward network that empowers Wnt signaling to drive mammary tumorigenesisMing-Zhu Zhang, Olivier Ferrigno, Zhe Wang, et al.
Pageof 410

Showing results (401-410 of 4,097) with videos related to

Sort By:
Pageof 410
Cancer Cell|March 12, 2015
Genomic analysis of smoothened inhibitor resistance in basal cell carcinomaHayley J Sharpe, Gregoire Pau, Gerrit J Dijkgraaf, et al.
Cancer Cell|March 12, 2015
Smoothened variants explain the majority of drug resistance in basal cell carcinomaScott X Atwood, Kavita Y Sarin, Ramon J Whitson, et al.
Cancer Cell|March 12, 2015
A cytoplasmic NF-κB interacting long noncoding RNA blocks IκB phosphorylation and suppresses breast cancer metastasisBodu Liu, Lijuan Sun, Qiang Liu, et al.
Cancer Cell|August 5, 2020
Clinical Challenges of Immune Checkpoint InhibitorsMaria de Miguel, Emiliano Calvo
Cancer Cell|May 12, 2023
Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in gliomaMohanraj Ramachandran, Alessandra Vaccaro, Tiarne van de Walle, et al.
Cancer Cell|April 28, 2023
Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancerMary Y Wu, Scott T C Shepherd, Annika Fendler, et al.
Cancer Cell|April 16, 2015
Releasing the brakes: targeting FcγRIIB on B cells to enhance antibody-dependent lymphoma immunotherapyMichaela Seeling, Falk Nimmerjahn
Cancer Cell|April 16, 2015
Antagonistic human FcγRIIB (CD32B) antibodies have anti-tumor activity and overcome resistance to antibody therapy in vivoAli Roghanian, Ingrid Teige, Linda Mårtensson, et al.
Cancer Cell|April 16, 2015
Synergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2Eric F Zhu, Shuning A Gai, Cary F Opel, et al.
Cancer Cell|April 16, 2015
TGIF governs a feed-forward network that empowers Wnt signaling to drive mammary tumorigenesisMing-Zhu Zhang, Olivier Ferrigno, Zhe Wang, et al.
Pageof 410